MOSO stock analysis – MSOS sold off & here is why it will keep going up

Signal: Moderna mRNA patent revoked by EPO after Pfizer suit – Pharmaceutical Technology

Share this article The Moderna dispute revolved around Pfizer and BioNTech’s Comirnaty vaccine. Photo: Md Rafayat Haque Khan/Eyepix Group/Future Publishing via Getty Images. Moderna‘s decision

November 22, 2023

What to Know About Nitazenes, a Class of Potent Synthetic Opioids

A class of synthetic opioids known as the nitazenes that are as potent as fentanyl — or stronger — have been increasingly involved in deaths

February 6, 2024

Rare immune cell holds key to predicting melanoma treatment success

A type of immune cell can help predict which patients may benefit most from cancer immunotherapies, researchers from King’s College London, Guy’s and St Thomas’

January 3, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.